Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleck, C.
Right arrow Articles by Rustenbeck, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleck, C.
Right arrow Articles by Rustenbeck, I.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:S135-S139, 2004
© 2004 by the American Diabetes Association, Inc.


Section III: The Beta-Cell ATP-Sensitive K+ Channels

Glucose Dependence of Imidazoline-Induced Insulin Secretion

Different Characteristics of Two ATP-Sensitive K+ Channel–Blocking Compounds

Claudia Bleck, Antje Wienbergen, and Ingo Rustenbeck

Institute of Pharmacology and Toxicology, University of Braunschweig, Braunschweig, Germany

The glucose dependence of the insulinotropic action of KATP channel–blocking imidazoline compounds was investigated. Administration of 100 µmol/l phentolamine, but not 100 µmol/l efaroxan, markedly increased insulin secretion of freshly isolated mouse islets when the perifusion medium contained 5 mmol/l glucose. When the glucose concentration was raised to 10 mmol/l in the continued presence of either imidazoline, a clear potentiation of secretion occurred as compared with 10 mmol/l glucose alone. In the presence of efaroxan, a brisk first-phase–like increase was followed by a sustained phase, whereas a more gradual increase resulted in the presence of phentolamine. Administration of 100 µmol/l phentolamine was somewhat more effective than 100 µmol/l efaroxan to inhibit KATP channel activity in intact cultured ß-cells (reduction by 96 vs. 83%). Both compounds were similarly effective to depolarize the ß-cells. When measured by the perforated patch-technique, the depolarization by efaroxan was often oscillatory, whereas that by phentolamine was sustained. In perifused cultured islets, both compounds increased the cytosolic calcium concentration ([Ca2+]c) in the presence of 5 and 10 mmol/l glucose. Efaroxan induced large amplitude oscillations of [Ca2+]c, whereas phentolamine induced a sustained increase. It appears that a KATP channel block by imidazolines is not incompatible with a glucose-selective enhancement of insulin secretion. The glucose selectivity of efaroxan may involve an inhibitory effect distal to [Ca2+]c increase and/or the generation of [Ca2+]c oscillations.


Address correspondence and reprint requests to Dr. I. Rustenbeck, Institute of Pharmacology and Toxicology, University of Braunschweig, Mendelssohnstrasse 1, D-38106 Braunschweig, Germany. E-mail: i.rustenbeck{at}tu-bs.de


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.